186 related articles for article (PubMed ID: 15292061)
1. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.
Houde C; Li Y; Song L; Barton K; Zhang Q; Godwin J; Nand S; Toor A; Alkan S; Smadja NV; Avet-Loiseau H; Lima CS; Miele L; Coignet LJ
Blood; 2004 Dec; 104(12):3697-704. PubMed ID: 15292061
[TBL] [Abstract][Full Text] [Related]
2. Loss of the SMRT/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma.
Ghoshal P; Nganga AJ; Moran-Giuati J; Szafranek A; Johnson TR; Bigelow AJ; Houde CM; Avet-Loiseau H; Smiraglia DJ; Ersing N; Chanan-Khan AA; Coignet LJ
Cancer Res; 2009 May; 69(10):4380-7. PubMed ID: 19417136
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.
Chiron D; Maïga S; Descamps G; Moreau P; Le Gouill S; Marionneau S; Ouiller T; Moreaux J; Klein B; Bataille R; Amiot M; Pellat-Deceunynck C
Blood Cells Mol Dis; 2012 Apr; 48(4):247-53. PubMed ID: 22341562
[TBL] [Abstract][Full Text] [Related]
6. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation.
Pietras A; von Stedingk K; Lindgren D; Påhlman S; Axelson H
Mol Cancer Res; 2011 May; 9(5):626-36. PubMed ID: 21402725
[TBL] [Abstract][Full Text] [Related]
7. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.
Takeuchi T; Adachi Y; Ohtsuki Y
Am J Pathol; 2005 Jun; 166(6):1817-26. PubMed ID: 15920166
[TBL] [Abstract][Full Text] [Related]
8. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
[TBL] [Abstract][Full Text] [Related]
9. [The significance of IGF-1, VEGF, IL-6 in multiple myeloma progression].
Guo YQ; Chen SL
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):231-4. PubMed ID: 16875552
[TBL] [Abstract][Full Text] [Related]
10. The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
Platonova N; Lazzari E; Colombo M; Falleni M; Tosi D; Giannandrea D; Citro V; Casati L; Ronchetti D; Bolli N; Neri A; Torricelli F; Crews LA; Jamieson CHM; Chiaramonte R
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834003
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
12. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
13. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Zhang L; Chen SL; Chen WM; Liu JW
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
[TBL] [Abstract][Full Text] [Related]
14. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
Jundt F; Pröbsting KS; Anagnostopoulos I; Muehlinghaus G; Chatterjee M; Mathas S; Bargou RC; Manz R; Stein H; Dörken B
Blood; 2004 May; 103(9):3511-5. PubMed ID: 14726396
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of vascular endothelial growth factors and their receptors in multiple myeloma.
Kimlinger T; Kline M; Kumar S; Lust J; Witzig T; Rajkumar SV
Haematologica; 2006 Aug; 91(8):1033-40. PubMed ID: 16870555
[TBL] [Abstract][Full Text] [Related]
16. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.
Nefedova Y; Cheng P; Alsina M; Dalton WS; Gabrilovich DI
Blood; 2004 May; 103(9):3503-10. PubMed ID: 14670925
[TBL] [Abstract][Full Text] [Related]
18. Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays.
De Vos J; Couderc G; Tarte K; Jourdan M; Requirand G; Delteil MC; Rossi JF; Mechti N; Klein B
Blood; 2001 Aug; 98(3):771-80. PubMed ID: 11468178
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
20. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures.
Lokhorst HM; Lamme T; de Smet M; Klein S; de Weger RA; van Oers R; Bloem AC
Blood; 1994 Oct; 84(7):2269-77. PubMed ID: 7919345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
